A Pilot Study Using Simvastatin in the Treatment of Nonalcoholic Steatohepatitis

Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia

1995 • 7,378 citations

Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease

1991 • 4,548 citations

Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions

1999 • 3,605 citations

PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA

1995 • 3,524 citations

The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study

2005 • 2,777 citations

Liver Biopsy

2001 • 1,920 citations

A Placebo-Controlled Trial of Pioglitazone in Subjects with Nonalcoholic Steatohepatitis

2006 • 1,700 citations

The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase.

1995 • 1,316 citations

Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors

1990 • 1,210 citations

Beyond insulin resistance in NASH: TNF-? or adiponectin?

2004 • 934 citations

CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis

2000 • 746 citations

Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trial

2004 • 723 citations

Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis

2003 • 704 citations

A Randomized Controlled Trial of Metformin versus Vitamin E or Prescriptive Diet in Nonalcoholic Fatty Liver Disease

2005 • 684 citations

Hepatic histology in obese patients undergoing bariatric surgery

2006 • 567 citations

Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis inob/ob mice

2005 • 526 citations

Chronic Exposure to Interleukin-6 Causes Hepatic Insulin Resistance in Mice

2003 • 477 citations

Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis

2004 • 455 citations

A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis

2004 • 438 citations

Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: A manifestation of lipotoxicity?

2002 • 368 citations

Abnormal Lipid and Glucose Metabolism in Obesity: Implications for Nonalcoholic Fatty Liver Disease

2007 • 321 citations

A pilot study of atorvastatin treatment in dyslipemid, non‐alcoholic fatty liver patients

2006 • 193 citations

The Evolving Role of Leptin and Adiponectin in Chronic Liver Diseases

2006 • 185 citations

Nonalcoholic steatohepatitis: what we know in the new millennium1

2002 • 177 citations

Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease

2006 • 173 citations

Ezetimibe improves liver steatosis and insulin resistance in obese rat model of metabolic syndrome

2007 • 163 citations

Leptin, obesity, and liver disease

1998 • 127 citations

Therapeutic options in non-alcoholic steatohepatitis (NASH). Are all agents alike? Results of a preliminary study.

2007 • 112 citations

Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

2003 • 108 citations

Direct Demonstration of an Antiinflammatory Effect of Simvastatin in Subjects with the Metabolic Syndrome

2006 • 105 citations

Association Between Nonalcoholic Fatty Liver, Markers of Obesity, and Serum Leptin Level in Young Adults

2002 • 81 citations

Orlistat Reverse Fatty Infiltration and Improves Hepatic Fibrosis in Obese Patients with Nonalcoholic Steatohepatitis (NASH)

2007 • 69 citations

Simvastatin (40 mg/day), Adiponectin Levels, and Insulin Sensitivity in Subjects With the Metabolic Syndrome

2007 • 50 citations

Probucol in the Treatment of Nonalcoholic Steatohepatitis

2003 • 42 citations

Adiponectin plasma levels are increased by atorvastatin treatment in subjects at high cardiovascular risk

2008 • 41 citations

Atorvastatin does not affect insulin sensitivity and the adiponectin or leptin levels in hyperlipidemic Type 2 diabetes

2008 • 39 citations

Atorvastatin reduces serum leptin concentration in hypercholesterolemic rabbits

2005 • 36 citations